NeuroPace, Inc. (NPCE)
NPCE Stock Price Chart
Explore NeuroPace, Inc. interactive price chart. Choose custom timeframes to analyze NPCE price movements and trends.
NPCE Company Profile
Discover essential business fundamentals and corporate details for NeuroPace, Inc. (NPCE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 Apr 2021
Employees
203.00
Website
https://www.neuropace.comCEO
Joel D. Becker
Description
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
NPCE Financial Timeline
Browse a chronological timeline of NeuroPace, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.19, while revenue estimate is $22.56m.
Earnings released on 12 May 2026
EPS came in at -$0.13 surpassing the estimated -$0.19 by +31.58%, while revenue for the quarter reached $22.00m , beating expectations by +1.64%.
Earnings released on 3 Mar 2026
EPS came in at -$0.08 surpassing the estimated -$0.14 by +42.86%, while revenue for the quarter reached $26.59m , beating expectations by +7.44%.
Earnings released on 4 Nov 2025
EPS came in at -$0.11 surpassing the estimated -$0.20 by +45.00%, while revenue for the quarter reached $27.35m , beating expectations by +9.27%.
Earnings released on 12 Aug 2025
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%, while revenue for the quarter reached $23.52m , missing expectations by -3.74%.
Earnings released on 13 May 2025
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%, while revenue for the quarter reached $22.52m , missing expectations by -0.82%.
Earnings released on 4 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.25 by +28.00%, while revenue for the quarter reached $21.47m , missing expectations by -0.44%.
Earnings released on 12 Nov 2024
EPS came in at -$0.19 surpassing the estimated -$0.26 by +26.92%, while revenue for the quarter reached $21.06m , beating expectations by +0.72%.
Earnings released on 13 Aug 2024
EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%, while revenue for the quarter reached $19.26m , beating expectations by +5.22%.
Earnings released on 8 May 2024
EPS came in at -$0.32 matching the estimated -$0.32, while revenue for the quarter reached $18.12m , beating expectations by +4.76%.
Earnings released on 5 Mar 2024
EPS came in at -$0.23 surpassing the estimated -$0.33 by +30.30%, while revenue for the quarter reached $18.01m , beating expectations by +3.16%.
Earnings released on 6 Nov 2023
EPS came in at -$0.28 surpassing the estimated -$0.39 by +28.21%, while revenue for the quarter reached $16.43m , beating expectations by +4.03%.
Earnings released on 8 Aug 2023
EPS came in at -$0.36 surpassing the estimated -$0.47 by +23.40%, while revenue for the quarter reached $16.51m , beating expectations by +30.82%.
Earnings released on 4 May 2023
EPS came in at -$0.41 surpassing the estimated -$0.46 by +10.87%, while revenue for the quarter reached $14.47m , beating expectations by +18.92%.
Earnings released on 2 Mar 2023
EPS came in at -$0.45 surpassing the estimated -$0.49 by +8.16%, while revenue for the quarter reached $12.79m , beating expectations by +5.09%.
Earnings released on 8 Nov 2022
EPS came in at -$0.48 surpassing the estimated -$0.52 by +7.69%, while revenue for the quarter reached $11.16m , beating expectations by +12.70%.
Earnings released on 11 Aug 2022
EPS came in at -$0.52 falling short of the estimated -$0.44 by -18.18%, while revenue for the quarter reached $10.20m , missing expectations by -7.94%.
Earnings released on 12 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%, while revenue for the quarter reached $11.37m , beating expectations by +6.86%.
Earnings released on 10 Mar 2022
EPS came in at -$0.44 falling short of the estimated -$0.33 by -33.33%, while revenue for the quarter reached $11.00m , missing expectations by -0.03%.
Earnings released on 10 Nov 2021
EPS came in at -$0.34 falling short of the estimated -$0.30 by -13.33%, while revenue for the quarter reached $10.34m , beating expectations by +15.38%.
Earnings released on 12 Aug 2021
EPS came in at -$0.36 surpassing the estimated -$0.39 by +7.69%, while revenue for the quarter reached $12.63m , beating expectations by +11.77%.
NPCE Stock Performance
Access detailed NPCE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
